Journals / Turkish Journal of Hematology / 2016 / Cilt: 33 - Sayı: 1

Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency

Glukoz-6-Fosfat Dehidrogenaz Eksikliği Taşıyıcısında Eltrombopag Yanıtlı İmmün Trombositopeni

Pages
77–78
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

NİSCOLA, P., PALOMBİ, M., TENDAS, A., GİOVANNİNİ, M., FABRİTİİS, P. D., SCARAMUCCİ, L. (2022). Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency. Turkish Journal of Hematology, Cilt: 33 - Sayı: 1, 77–78. https://ajindex.com/articles/606842

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Tripathi AK, Shukla A, Mishra S, Yadav YS, Yadav DK. Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients. Int J Hematol 2014;99:413-417
  2. Luzzatto L, Seneca E. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol 2014;164:469-480
  3. No authors listed. Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bull World Health Organ 1989;67:601-611
  4. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008;371:64-74. 5. van de Mheen L, Smits SM, Terpstra WE, Leyte A, Bekedam DJ, van den Akker ES. Haemolytic anaemia after nitrofurantoin treatment in a pregnant woman with G6PD deficiency. BMJ Case Rep 2014:2014.